Sentinel lymph node mapping in gynecological oncology

被引:5
作者
Du, Jiang [1 ]
Li, Yaling [2 ]
Wang, Qing [1 ]
Batchu, Nasra [1 ]
Zou, Junkai [1 ]
Sun, Chao [1 ]
Lv, Shulan [1 ]
Song, Qing [1 ,3 ,4 ]
Li, Qiling [1 ,4 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
[2] Gongzhuling Hlth Workers High Sch, Gongzhuling 136100, Jilin, Peoples R China
[3] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA
[4] Xian Jiatong Univ, Big Data Ctr, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
sentinel lymph node mapping; gynecological oncology; dyes; STAGE CERVICAL-CANCER; MINIMALLY INVASIVE SURGERY; SQUAMOUS-CELL CARCINOMA; BLUE-DYE INJECTION; ENDOMETRIAL CANCER; INDOCYANINE GREEN; VULVAR CANCER; BREAST-CANCER; PATENT BLUE; RADICAL HYSTERECTOMY;
D O I
10.3892/ol.2017.7219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The intraoperative mapping of sentinel lymph nodes (SLNs) is part of the treatment strategy for a number of types of tumor. To retrospectively compare results from the mapping of pelvic SLNs for gynecological oncology, using distinct dyes, the present review was conducted to determine the clinical significance of SLN mapping for gynecological oncology. In addition, the present study aimed at identifying an improved choice for SLN mapping tracers in clinical application. Each dye exhibits demerits when applied in the clinical environment. The combination of radioisotopes and blue dyes was identified to exhibit the most accurate detection rate of SLN drainage of gynecological oncology. However, contrast agents were unable to identify whether a SLN is positive or negative for metastasis prior to pathologic examination; additional studies are required.
引用
收藏
页码:7669 / 7675
页数:7
相关论文
共 125 条
  • [1] Techniques of sentinel lymph node identification for early-stage cervical and uterine cancer
    Abu-Rustum, Nadeem R.
    Khoury-Collado, Fady
    Gemignani, Mary L.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : S44 - S50
  • [2] Acharya BC, 2009, J NEPAL MED ASSOC, V48, P287
  • [3] Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review
    Ahmed, Muneer
    Purushotham, Arnie D.
    Douek, Michael
    [J]. LANCET ONCOLOGY, 2014, 15 (08) : E351 - E362
  • [4] Detection and credibility of sentinel node in vulvar cancer: a single institutional study and short review of literature
    Akrivos, Nikolaos
    Rodolakis, Alexandros
    Vlachos, George
    Sotiropoulou, Maria
    Papantoniou, Vasileios
    Biliatis, Ioannis
    Haidopoulos, Dimitrios
    Thomakos, Nikolaos
    Simou, Maria
    Antsaklis, Aris
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 284 (06) : 1551 - 1556
  • [5] Ansari M, 2013, EUR J GYNAECOL ONCOL, V34, P387
  • [6] Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature
    Ayhan, Ali
    Celik, Husnu
    Dursun, Polat
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
  • [7] Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer
    Ballester, Marcos
    Rouzier, Roman
    Coutant, Charles
    Kerrou, Khaldoun
    Darai, Emile
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : 348 - 352
  • [8] Value of intraoperative imprint cytology of sentinel nodes in patients with cervical cancer
    Barranger, E
    Cortez, A
    Uzan, S
    Callard, P
    Darai, E
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 94 (01) : 175 - 180
  • [9] Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience
    Barthelmes, L.
    Goyal, A.
    Newcombe, R. G.
    McNeill, F.
    Mansel, R. E.
    [J]. EJSO, 2010, 36 (04): : 399 - 403
  • [10] Benedet J L, 2001, J Epidemiol Biostat, V6, P7